Partnerships and Licensing
ProCode
- Human monoclonal antibody drug selection and affinity maturation to coexpressed target molecules
- Protein solubility improvement
ProCode is available for partnership and/or licensing for developing monoclonal antibody based drugs. ProCode is “stand alone” technology with novel diversity libraries for selection of binders. ProCode has a low royalty burden and offers rapid development timelines.
Pegylation Technology
- 100% specificity on a single amino acid
- Up to 80% efficiency of pegylation
Vybion offers full development programs for bring molecules from discovery through expression, scale up and manufacturing. Vybion’s extensive experience crosses multiple therapeutic areas.
